- Report
- November 2024
- 89 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2024
- 111 Pages
Global
From €3500EUR$3,929USD£3,035GBP
From €114EUR$119USD£95GBP
- Book
- February 2020
- 459 Pages
From €123EUR$129USD£103GBP
- Book
- July 2023
- 272 Pages
- Book
- April 2020
- 336 Pages
- Book
- December 2024
- 1440 Pages
- Book
- July 2023
- 272 Pages
- Book
- September 2013
- 352 Pages
- Book
- June 2012
- 596 Pages
- Book
- April 2010
- 754 Pages

The Inflammation market within the context of Allergy and Immunology is a rapidly growing field of research and development. It focuses on the study of the body's immune system and its response to allergens, pathogens, and other foreign substances. This includes the development of treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. The market is driven by the increasing prevalence of allergies and autoimmune diseases, as well as the need for more effective treatments.
The Inflammation market is composed of a variety of companies, ranging from pharmaceuticals to biotechnology firms. These companies are focused on developing new treatments and therapies to reduce inflammation and improve the body's ability to fight off infection. Examples of companies in this market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more